Candel Therapeutics News

Candel Therapeutics to Present Promising Cancer Trial Data

TipRanksApr 25 20:42

Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting

NEEDHAM, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biolo

GlobeNewswireApr 25 20:00

CVAC, SBNY and CRMD Are Among After Hour Movers

Seeking AlphaApr 18 05:01

Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology

ACN NewswireApr 16 18:01

GLYC, APLD and AUTL Are Among After Hour Movers

Seeking AlphaApr 12 05:00

Trending Stocks Today: Rent the Runway Surges 127.63%

April 11th - US stocks trending in regular trading hours.Gainers: $Rent the Runway(RENT.US)$ shoots up 127.63% to $16.85 with a turnover of $667.53 million. $Rallybio(RLYB.US)$ surges 79.14% to $2.92

Futu NewsApr 12 02:00

Sector Update: Health Care Stocks Decline Thursday Afternoon

Health care stocks were softer Thursday afternoon, with the NYSE Health Care Index decreasing 0.2% and the Health Care Select Sector SPDR Fund (XLV) down less than 0.1%. The iShares Biotechnology ETF

MT NewswiresApr 12 01:57

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Fastenal Company (NASDAQ:FAST) fell sharply during Thursday's session following worse-than-expected first-quarter financial results. Fastenal reported first-quarter FY24 sales growth of 1.9

BenzingaApr 12 01:33

NKTR, VERU and EGIO Among Mid-day Movers

Seeking AlphaApr 12 00:55

What's Going On With Candel Therapeutics Stock?

Candel Therapeutics, Inc. (NASDAQ:CADL) shares are trading higher Thursday after the company received FDA orphan drug designation for CAN-2409 for the treatment of pancreatic cancer.The Details:"We re

BenzingaApr 11 23:39

Candel Therapeutics Shares Leap Premarket on FDA Orphan-Drug Designation

Shares of Candel Therapeutics jumped nearly 30% in premarket trading Thursday after the clinical-stage biopharmaceutical company won a key U.S. Food and Drug Administration designation for the lead product candidate from the adenovirus platform.

WSJApr 11 21:15

Candel Therapeutics Gains Orphan Drug Status for Cancer Treatment

TipRanksApr 11 21:12

Candel Therapeutics Shares Are Trading Higher After the Company Received FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer.

Candel Therapeutics Shares Are Trading Higher After the Company Received FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer.

BenzingaApr 11 21:09

Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer

Candel Therapeutics, Inc.(Nasdaq: CADL) today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to CAN-2409, Candel's most advanced multimodal biological immunotherapy candidate, for the treatment of pancreatic cancer.

GlobeNewswireApr 11 21:00

BSGM, WAVE and TCBP Among Pre-market Losers

Seeking AlphaApr 10 20:22

AEYE, GSIT and VVPR Among Mid-day Movers

Seeking AlphaApr 10 01:05

Candel Therapeutics Unveils Breakthrough Immunotherapy Candidate

TipRanksApr 9 20:43

Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors

First-in-class multimodal immunotherapy candidate, for induction of tertiary lymphoid structures, being developed as a novel therapeutic strategy for solid tumors from the enLIGHTEN Discovery PlatformDelivery of

GlobeNewswireApr 9 20:00

PERI, ITRM and CADL Among Pre-market Losers

Seeking AlphaApr 8 20:23

Retail Investors Invested in Candel Therapeutics, Inc. (NASDAQ:CADL) up 320% Last Week, Insiders Too Were Rewarded

Yahoo FinanceApr 6 22:00